Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,808
Sort by:
Adalimumab, Infliximab And Etanercept Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Adalimumab Biosimilars, Infliximab Biosimilars, Cipleumab), By Application (Crohn’s Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis, Other Applications), By Distribution Channel
US$ 3,950.00
The Adalimumab, Infliximab And Etanercept Biosimilars Market is valued at USD 6.4 billion in 2025 and is projected to grow at a CAGR of 16.7% to reach USD 25.6 billion by 2034.The adalimumab, inflixim...
October 2025
160 pages
Bioinformatics Services Market Outlook 2025-2034: Market Share, and Growth Analysis By Service (Sequencing Services, Data Analysis, Drug Discovery Services, Differential Gene Expression Analysis, Database And Management Services, Other Services), By Specialty (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology), By Application, By End User
US$ 3,950.00
The Bioinformatics Services Market is valued at USD 6.1 billion in 2025 and is projected to grow at a CAGR of 17.3% to reach USD 25.7 billion by 2034.The bioinformatics services market has been expand...
October 2025
160 pages
Cell Regeneration Medicine Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Therapeutics, Tools, Banks, Services), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology And Inflammation, Oncology, Cardiovascular, Ophthalmology, Other Therapeutic Categories), By End-User
US$ 3,950.00
The Cell Regeneration Medicine Market is valued at USD 39.3 billion in 2025 and is projected to grow at a CAGR of 14% to reach USD 127.7 billion by 2034.The cell regeneration medicine market is a rapi...
October 2025
160 pages
Gene Expression Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Kits And Reagents, DNA Chip Or Microarray, Other Products), By Process (Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation), By Technique, By Application
US$ 3,950.00
The Gene Expression Market is valued at USD 11.1 billion in 2025 and is projected to grow at a CAGR of 11.8% to reach USD 30.2 billion by 2034. Gene Expression Market Overview The Gene Expression Mark...
October 2025
160 pages
Biologic & Biosimilar Ra Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Source (Microbial, Mammalian, Other Sources), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Other Diseases), By Manufacturing, By Mode Of Purchase, By Distribution Channel
US$ 3,950.00
The Biologic & Biosimilar Ra Drugs Market is valued at USD 12.1 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 19.5 billion by 2034.The market for biologic and biosimilar rheu...
October 2025
160 pages
Biosimilar Growth Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis By Route Of Administration (Intravenous, Subcutaneous, Intramuscular, Oral), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications), By Distribution Channel
US$ 3,950.00
The Biosimilar Growth Hormones Market is valued at USD 1010.4 million in 2025 and is projected to grow at a CAGR of 8.7% to reach USD 2131.9 million by 2034.The Biosimilar Growth Hormones Market is ex...
October 2025
160 pages
Biosimilar Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications), By Distribution Channel
US$ 3,950.00
The Biosimilar Hormones Market is valued at USD 7.9 billion in 2025 and is projected to grow at a CAGR of 22.8% to reach USD 50.3 billion by 2034.The Biosimilar Hormones Market is experiencing robust...
October 2025
160 pages
Biosimilar Interleukins Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Other Applications), By Distribution Channel
US$ 3,950.00
The Biosimilar Interleukins Market is valued at USD 9.3 billion in 2025 and is projected to grow at a CAGR of 34.7% to reach USD 135.9 billion by 2034.The Biosimilar Interleukins Market is emerging as...
October 2025
160 pages
Biosimilar Monoclonal Antibodies Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Synthetic Chemicals, Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Application
US$ 3,950.00
The Biosimilar Monoclonal Antibodies Market is valued at USD 9.3 billion in 2025 and is projected to grow at a CAGR of 14% to reach USD 30.3 billion by 2034.The Biosimilar Monoclonal Antibodies Market...
October 2025
160 pages
Bone Marrow Transplantation Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Autologous Bone Marrow Transplant, Allogenic Bone Marrow Transplant), By Indication (Hodgkin Lymphoma, Acute Leukemia, Multiple Myelomas, Solid Tumors, Non-Hodgkin Lymphoma, Other Indications), By End-Users
US$ 3,950.00
The Bone Marrow Transplantation Market is valued at USD 9.9 billion in 2025 and is projected to grow at a CAGR of 6.6% to reach USD 17.6 billion by 2034.Bone marrow transplantation (BMT) is a critical...
October 2025
160 pages
Clinical Oncology Next Generation Sequencing Market Outlook 2025-2034: Market Share, and Growth Analysis By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing), By Application (Screening, Companion Diagnostics, Other Diagnostics), By End User
US$ 3,950.00
The Clinical Oncology Next Generation Sequencing Market is valued at USD 613.4 million in 2025 and is projected to grow at a CAGR of 15.2% to reach USD 2190.2 million by 2034.The clinical oncology nex...
October 2025
160 pages
Genomics Personalized Health Market Outlook 2025-2034: Market Share, and Growth Analysis By Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Other Test Type), By Technology (NGS platforms, RT-PCR, Microarray, Genetic Analyzers), By End User
US$ 3,950.00
The Genomics Personalized Health Market is valued at USD 16.6 billion in 2025 and is projected to grow at a CAGR of 14.2% to reach USD 54.9 billion by 2034.The genomics personalized health market is t...
October 2025
160 pages
Healthcare Nanotechnology Market Outlook 2025-2034: Market Share, and Growth Analysis By Disease (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases), By Type (Organic, Inorganic, Carbon-Based), By Application
US$ 3,950.00
The Healthcare Nanotechnology Market is valued at USD 341.5 billion in 2025 and is projected to grow at a CAGR of 14.5% to reach USD 1153.3 billion by 2034.The Healthcare Nanotechnology Market is rapi...
October 2025
160 pages
Implantable Biomaterials Market Outlook 2025-2034: Market Share, and Growth Analysis By Material (Metallic, Ceramic, Polymers, Natural), By Application (Dental, Cardiovascular, Ophthalmology, Orthopedic, Other Applications), By End-user
US$ 3,950.00
The Implantable Biomaterials Market is valued at USD 139.5 billion in 2025 and is projected to grow at a CAGR of 11.6% to reach USD 374.3 billion by 2034.The Implantable Biomaterials Market is a rapid...
October 2025
160 pages
Oral Biologics & Biosimilar Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type, By Distribution Channel
US$ 3,950.00
The Oral Biologics & Biosimilar Drugs Market is valued at USD 10.5 billion in 2025 and is projected to grow at a CAGR of 18.7% to reach USD 49.1 billion by 2034.The oral biologics and biosimilar drugs...
October 2025
160 pages
Oral Biologics & Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors, Immunostimulants, GPCR Modulators, Other Therapies), By Disease (Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases), By Molecule Type, By Distribution Channel
US$ 3,950.00
The Oral Biologics & Biosimilars Market is valued at USD 7.7 trillion in 2025 and is projected to grow at a CAGR of 16.2% to reach USD 29.8 trillion by 2034.The oral biologics and biosimilars market h...
October 2025
160 pages
Polymer Biomaterial Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Nylon, Silicone Rubber, Polyester, Polymethyl Methacrylate (PMMA), Polyethylene (PE), Polyvinyl Chloride, Other Types), By Nature (Natural, Synthetic), By Application
US$ 3,950.00
The Polymer Biomaterial Market is valued at USD 77.2 billion in 2025 and is projected to grow at a CAGR of 20% to reach USD 396.8 billion by 2034. Polymer Biomaterial Market Overview The polymer bioma...
October 2025
160 pages
Regenerative Medicine For Cartilage Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Modality ( Cell-Based, Non-Cell-Based), By Treatment Type ( Palliative, Intrinsic Repair Stimulus, Others Skin Resurfacing ), By Site, By Application, By End-User: Ambulatory Surgical Centers, Hospitals & Clinics)
US$ 3,950.00
The Regenerative Medicine For Cartilage Market is valued at USD 5.8 billion in 2025 and is projected to grow at a CAGR of 5.2% to reach USD 9.1 billion by 2034.The Regenerative Medicine for Cartilage...
October 2025
160 pages
Remicade Biosimilar Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (100mg/10ml, 500mg/50ml), By Disease Indication (Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriatic Arthritis, Plaque Psoriasis), By Application
US$ 3,950.00
The Remicade Biosimilar Market is valued at USD 5.8 billion in 2025 and is projected to grow at a CAGR of 21.7% to reach USD 34 billion by 2034.The Remicade Biosimilar Market has gained substantial mo...
October 2025
160 pages
Ribonucleic Acid (Rna) Sequencing Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Instruments, Reagents And Kits, Software), By Technology (Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing), By Applications, By End User
US$ 3,950.00
The Ribonucleic Acid (Rna) Sequencing Market is valued at USD 4.6 billion in 2025 and is projected to grow at a CAGR of 19.3% to reach USD 22.5 billion by 2034.The Ribonucleic Acid (RNA) Sequencing Ma...
October 2025
160 pages
Single-Cell Genome Sequencing Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Instruments, Reagents), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)), By Disease Area, By Application, By End User
US$ 3,950.00
The Single-Cell Genome Sequencing Market is valued at USD 3.5 billion in 2025 and is projected to grow at a CAGR of 12.7% to reach USD 10.3 billion by 2034.The single-cell genome sequencing market rep...
October 2025
160 pages
Single-Cell Omics Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics), By Technology (Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing), By Application, By End-User
US$ 3,950.00
The Single-Cell Omics Market is valued at USD 2.9 billion in 2025 and is projected to grow at a CAGR of 15.5% to reach USD 10.6 billion by 2034.The single-cell omics market represents a transformative...
October 2025
160 pages
Trastuzumab Biosimilars Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Ogivri, Herzuma, Ontruzant, Trazimera, Other Products), By Indication (Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer, Other Indications), By Distribution Channel
US$ 3,950.00
The Trastuzumab Biosimilars Market is valued at USD 8.1 billion in 2025 and is projected to grow at a CAGR of 24.1% to reach USD 56.6 billion by 2034.The Trastuzumab Biosimilars Market has emerged as...
October 2025
160 pages
3D Scaffolds Market Size, Share & Trends Analysis Report By Type, By Application (Tissue Engineering & Regenerative Medicine, Stem Cell Research), By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global 3D scaffolds market size was valued at USD 909.5 million in 2024 and is projected to reach USD 2,008.6 million by 2033, growing at a CAGR of 9.53% from 2025 to 2033. This growth is driven b...
October 2025
110 pages
Stem Cell Therapy Market - 2024-2033
US$ 2,999.00
The Stem Cell Therapy Market was valued at US$ 16.44 billion in 2024 and is anticipated to reach US$ 45.69 billion by 2033, at a CAGR of 0.127 from 2026 to 2032. The report delivers in-depth insights...
October 2025
220 pages
Global Collagen Biomaterial Market Growth 2025-2031
US$ 3,660.00
... the base year being 2017) and the growth prospects of global Collagen Biomaterial market for 2018-2023. Collagen Biomaterial is proteins that are used in biotechnology applications to focus ...
October 2025
96 pages
Global Tissue-Replacement Products Market Growth 2025-2031
US$ 3,660.00
The global Tissue-Replacement Products market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the lates...
October 2025
88 pages
Global Biosimilars Market Growth 2025-2031
US$ 3,660.00
The global Biosimilars market size is predicted to grow from US$ 9192 million in 2025 to US$ 25670 million in 2031; it is expected to grow at a CAGR of 18.7% from 2025 to 2031. The impact of the lates...
October 2025
155 pages
Global Nanomedicine Market - 2023-2033
US$ 2,999.00
The Global Nanomedicine Market was valued at US$ 155.51 Billion in 2023 and is anticipated to reach US$ 389.52 Billion by 2033, at a CAGR of 0.097 from 2026 to 2032. The report delivers in-depth insig...
October 2025
219 pages
Global Nano-Drug Market Growth 2025-2031
US$ 3,660.00
The global Nano-Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff meas...
October 2025
155 pages
Global Ortho Biological Products Market Growth 2025-2031
US$ 3,660.00
The global Ortho Biological Products market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
115 pages
Global Tissue Engineered Bone Market Growth 2025-2031
US$ 3,660.00
The global Tissue Engineered Bone market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S...
October 2025
104 pages
Global Amniotic Membranes Market Growth 2025-2031
US$ 3,660.00
The global Amniotic Membranes market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. ta...
October 2025
85 pages
Genomics Data Analysis Market Size, Share & Trends Analysis Report By Service (Variant Calling & Annotation, Gene Expression Analysis), By Technology (NGS, Microarray, PCR), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global genomics data analysis market size was estimated at USD 5.68 billion in 2024 and is projected to reach USD 20.49 billion by 2033, growing at a CAGR of 15.40% from 2025 to 2033. This growth...
October 2025
120 pages
